Increased transplant arteriosclerosis in the absence of CCR7 is associated with reduced expression of Foxp3

Transplantation

Volumn 86, Issue 4, 2008, Pages 590-600

  Ensminger, Stephan M ^a   Helm, Stephanie N ^a   Ohl, Lars ^b   Spriewald, Bernd M ^a   Abele, Silke ^a   Wollin, Martina ^a   Wood, Kathryn J ^c   Weyand, Michael ^a   Förster, Reinhold ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cell trafficking; Chemokines; Secondary lymphoid organs; Transplantation

Indexed keywords

CHEMOKINE RECEPTOR CCR7; EOTAXIN; INTERLEUKIN 12; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; CCR7 PROTEIN, MOUSE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE;

ABDOMINAL AORTA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA GRAFT; AORTA INTIMA; ARTERIOSCLEROSIS; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC ASSOCIATION; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; ALLOTRANSPLANTATION; ANIMAL; AORTA; CBA MOUSE; GENETICS; IMMUNOLOGY; LYMPHOCYTE COUNT; POSTOPERATIVE COMPLICATION; REGULATORY T LYMPHOCYTE; TRANSPLANTATION;

ANIMALS; AORTA; ARTERIOSCLEROSIS; FORKHEAD TRANSCRIPTION FACTORS; LYMPHOCYTE COUNT; MICE; MICE, INBRED CBA; POSTOPERATIVE COMPLICATIONS; RECEPTORS, CCR7; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 52449124768     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181826a97     Document Type: Article

References (49)

1. Nelson PJ, Krensky AM. Chemokines, chemokine receptors, and allograft rejection. Immunity 2001; 14: 377.
2. Sallusto F, Kremmer E, Palermo B, et al. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur J Immunol 1999; 29: 2037.
3. Kapoor A, Fairchild RL. Early and late chemokine cascades during acute allograft rejection. Transplant Rev 2000; 14: 82.
4. Lalor PF, Adams DH. Lymphocyte homing to allografts. Transplantation 2000; 70: 1131.
5. Hancock WW. Chemokine receptor-dependent alloresponses. Immunol Rev 2003; 196: 37.
6. de Vries AP, Bakker SJ, van Son WJ, et al. Insulin resistance as putative cause of chronic renal transplant dysfunction. Am J Kidney Dis 2003; 41: 859.
7. Gao W, Topham PS, King JA, et al. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allo-graft rejection. J Clin Invest 2000; 105: 35.
8. Gao W, Faia KL, Csizmadia V, et al. Beneficial effects of targeting ccr5 in allograft recipients. Transplantation 2001; 72: 1199.
9. Hancock WW, Lu B, Gao W, et al. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 2000; 192: 1515.
10. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000; 18: 593.
11. Ibrahim AI, Obeid MT, Jouma MJ, et al. Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts. J Clin Virol 2005; 32: 29.
12. Förster R, Schubel A, Breitfeld D, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999; 99: 23.
13. Sallusto F, Lenig D, Forster R, et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708.
14. Worbs T, Forster R. A key role for CCR7 in establishing central and peripheral tolerance. Trends Immunol 2007; 28: 274.
15. Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science 1999; 286: 2098.
16. Beckmann JH, Yan S, Luhrs H, et al. Prolongation of allograft survival in CCR7-deficient mice. Transplantation 2004; 77: 1809.
17. Bushell A, Niimi M, Morris PJ, et al. Evidence for immune regulation in the induction of transplantation tolerance: A conditional but limited role for IL-4. J Immunol 1999; 162: 1359.
18. Turvey SE, Hara M, Morris PJ, et al. Mechanisms of tolerance induction after intrathymic islet injection: Determination of the fate of alloreactive thymocytes. Transplantation 1999; 68: 30.
19. Koulack J, McAlister VC, Giacomantonio CA, et al. Development of a mouse aortic transplant model of chronic rejection. Microsurgery 1995; 16: 110.
20. + T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade. Transplantation 2000; 69: 2609.
21. Niimi M, Hara M, Witzke O, et al. Donor resting B cells induce indefinite prolongation of fully allogeneic cardiac grafts when delivered with anti-immunoglobulin-D monoclonal antibody: Evidence for tolerogenicity of donor resting B cells in vivo. Transplantation 1998; 66: 1786.
22. Ensminger SM, Spriewald BM, Witzke O, et al. Kinetics of transplant arteriosclerosis in MHC-Class I mismatched and fully allogeneic mouse aortic allografts. Transplantation 2002; 73: 1068.
23. Overbergh L, Valckx D, Waer M, et al. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR Cytokine 1999; 11: 305.
24. Ensminger SM, Spriewald BM, Sorensen HV, et al. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation. J Immunol 2001; 167: 532.
25. Tilney N. Chronic rejection and its risk factors. Transplant Proc 1999; 13: 41S.
26. Rose ML. Role of antibodies in rejection. Curr Opin Organ Transplant 1999; 4: 227.
27. Weis M. Cardiac allograft vasculopathy: Prevention and treatment options. Transplant Proc 2002; 34: 1847.
28. Lietz K, Miller LW. Current understanding and management of allograft vasculopathy. Semin Thorac Cardiovasc Surg 2004; 16: 386.
29. Forster R, Schubel A, Breitfeld D, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999; 99: 23.
30. Hopken UE, Droese J, Li JP, et al. The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses. Eur J Immunol 2004; 34: 461.
31. Han S, Zheng B, Takahashi Y, et al. Distinctive characteristics of germinal center B cells. Semin Immunol 1997; 9: 255.
32. Martin F, Chan AC. B cell immunobiology in disease: Evolving concepts from the clinic. Annu Rev Immunol 2006; 24: 467.
33. Uehara S, Chase CM, Cornell LD, et al. Chronic cardiac transplant arteriopathy in mice: Relationship of alloantibody, C4d deposition and neointimal fibrosis. Am J Transplant 2007; 7: 57.
34. Russell PS, Chase CM, Winn HJ, et al. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol 1994; 152: 5135.
35. Chow LH, Huh S, Jiang J, et al. Intimal thickening develops without humoral immunity in a mouse aortic allograft model of chronic vascular rejection. Circulation 1996; 94: 3079.
36. Wise MP, Zelenika D, Bemelman F, et al. CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts. Eur J Immunol 1999; 29: 156.
37. Bundy RE, Marczin N, Birks EF, et al. Transplant atherosclerosis: Role of phenotypic modulation of vascular smooth muscle by nitric oxide. Gen Pharmacol 2000; 34: 73.
38. Cailhier JF, Laplante P, Hebert MJ. Endothelial apoptosis and chronic transplant vasculopathy: Recent results, novel mechanisms. Am J Transplant 2006; 6: 247.
39. Ensminger SM, Billing JS, Morris PJ, et al. Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse. J Heart Lung Transplant 2000; 19: 1039.
40. Cobbold SP, Adams E, Graca L, et al. Immune privilege induced by regulatory T cells in transplantation tolerance. Immunol Rev 2006; 213: 239.
41. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151.
42. Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new fork- head/winged-helix protein, scurfin, results in the fatal lymphoprolif-erative disorder of the scurfy mouse. Nat Genet 2001; 27: 68.
43. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057.
44. + regulatory T cells. Nat Immunol 2003; 4: 330.
45. + T regulatory cells. Nat Immunol 2003; 4: 337.
46. Kocks JR, Davalos-Misslitz AC, Hintzen G, et al. Regulatory T cells interfere with the development of bronchus-associated lymphoid tissue. J Exp Med 2007; 204: 723.
47. + regulatoryTcells. J Exp Med 2007; 204:735.
48. Worbs T, Mempel TR, Bolter J, et al. CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo. J Exp Med 2007; 204:489.
49. Schroeder G, Risch K, Kotsch K, et al. FTY720 prevents anti-CD4 mAb-induced tolerance but cannot reverse established tolerance in a rat kidney transplantation model. Am J Transplant 2004; 4: 863.